{"id":3426,"date":"2024-12-17T12:31:21","date_gmt":"2024-12-17T11:31:21","guid":{"rendered":"https:\/\/invivo.partners\/?post_type=equipo&#038;p=3426"},"modified":"2024-12-19T15:05:11","modified_gmt":"2024-12-19T14:05:11","slug":"michael-tadros","status":"publish","type":"equipo","link":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/","title":{"rendered":"Michael Tadros"},"content":{"rendered":"<p>Michael \u00e9s un l\u00edder en biotecnologia amb una llicenciatura en Biologia Cel\u00b7lular i Molecular i un doctorat en Microbiologia. T\u00e9 una \u00e0mplia experi\u00e8ncia en transfer\u00e8ncia de tecnologia, filantropia de risc i gesti\u00f3 de biotecnologia, impulsant innovacions basades en la recerca cap al mercat.<\/br><\/br><br \/>\nAnteriorment, Michael va ser gestor a CrossRoadBiotech, una firma de capital risc en ci\u00e8ncies de la vida, i posteriorment Senior Manager a la Fundaci\u00f3 Bot\u00edn, donant suport als cient\u00edfics l\u00edders d\u2019Espanya mitjan\u00e7ant gesti\u00f3 estrat\u00e8gica i finan\u00e7ament.<\/br><\/br><\/p>\n<p>Com a Global COO i CEO a la UE a DanausGT, va liderar ter\u00e0pies CRISPR AAV fins a assajos cl\u00ednics en humans, acumulant experi\u00e8ncia en presentacions i aprovacions, planificaci\u00f3 i execuci\u00f3 de desenvolupament complet, desenvolupament cl\u00ednic, gesti\u00f3 general, lideratge d\u2019equips i desenvolupament de negoci.<\/br><\/br><\/p>\n<p>Actualment \u00e9s CEO de Telomere Therapeutics, on va col\u00b7laborar amb els fundadors i Invivo per establir la companyia el 2020, centrant-se en ter\u00e0pies g\u00e8niques per a s\u00edndromes de tel\u00f2mers. Tamb\u00e9 assessora i fa de mentor per a emprenedors en biotecnologia i organismes d\u2019innovaci\u00f3 a Europa i Canad\u00e0.<\/br><\/br><\/p>\n","protected":false},"template":"","class_list":["post-3426","equipo","type-equipo","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Michael Tadros - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael Tadros - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Michael \u00e9s un l\u00edder en biotecnologia amb una llicenciatura en Biologia Cel\u00b7lular i Molecular i un doctorat en Microbiologia. T\u00e9 una \u00e0mplia experi\u00e8ncia en transfer\u00e8ncia de tecnologia, filantropia de risc i gesti\u00f3 de biotecnologia, impulsant innovacions basades en la recerca cap al mercat. Anteriorment, Michael va ser gestor a CrossRoadBiotech, una firma de capital risc\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-19T14:05:11+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/\",\"url\":\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/\",\"name\":\"Michael Tadros - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2024-12-17T11:31:21+00:00\",\"dateModified\":\"2024-12-19T14:05:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Michael Tadros\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michael Tadros - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/","og_locale":"ca_ES","og_type":"article","og_title":"Michael Tadros - Invivo Partners","og_description":"Michael \u00e9s un l\u00edder en biotecnologia amb una llicenciatura en Biologia Cel\u00b7lular i Molecular i un doctorat en Microbiologia. T\u00e9 una \u00e0mplia experi\u00e8ncia en transfer\u00e8ncia de tecnologia, filantropia de risc i gesti\u00f3 de biotecnologia, impulsant innovacions basades en la recerca cap al mercat. Anteriorment, Michael va ser gestor a CrossRoadBiotech, una firma de capital risc","og_url":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/","og_site_name":"Invivo Partners","article_modified_time":"2024-12-19T14:05:11+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/","url":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/","name":"Michael Tadros - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2024-12-17T11:31:21+00:00","dateModified":"2024-12-19T14:05:11+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/equipo\/michael-tadros\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Michael Tadros"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/equipo\/3426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/equipo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/equipo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=3426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}